PROK ProKidney Corp
356
$4.06
$0.265
(6.99%)
| Watchers | 356 |
| 52-Wk Low | $1.12 |
| 52-Wk High | $13.51 |
| Market Cap | $259.21M |
| Volume | 546,776.00 |
| 52-Wk High | $13.51 |
| 52-Wk Low | $1.12 |
ProKidney appoints Ulrich Ernst as EVP, technical operationsThe Fly • about 2 months ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
Dr. Ulrich Ernst joins as Executive Vice President of Technical Operations with a deep background and expertise in process development and manufacturing of cell therapies Mr. Lucio Tozzi joined in...
WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ( ProKidney or the Company"), a leading late clinical-stage cellular therapeutics company focused on chronic...
Morgan Stanley initiated coverage on shares of ProKidney (NASDAQ:PROK Free Report) in a research note issued to investors on Thursday, Marketbeat reports. The brokerage issued an equal weight...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
WINSTON-SALEM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ( ProKidney ), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease...
ProKidney (NASDAQ:PROK Get Free Report) and Cabaletta Bio (NASDAQ:CABA Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the...